search
Back to results

Botulinum for Chronic Exertional Compartment Syndrome (Botox)

Primary Purpose

Chronic Exertional Compartment Syndrome

Status
Terminated
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Botulinum toxin injections for chronic compartment syndrome
surgical fasciotomy for chronic compartment syndrome
Sponsored by
375th Medical Group, Scott Air Force Base
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Exertional Compartment Syndrome

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult ages 18-65
  • Active duty military
  • Unable to run 1.5 miles without producing symptoms, including aching, burning, numbness, tingling, or weakness in the affected limb
  • Failed conservative treatment over a period of 2 months, including trial of rest, NSAIDs, icing, and stretching routine
  • Meets standard of care clinical diagnostic intramuscular compartment pressure criteria for CECS, based on standardized IMP needle testing. See below for testing protocol and criteria.

Exclusion Criteria:

  • Prior Botulinum toxin injections into the affected limb
  • Prior compartment release of the affected limb
  • Pregnant or becomes pregnant during the study
  • Standard of care clinical exams indicating other more likely causes of leg pain

Sites / Locations

  • 375th Medical Group

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Botulinum toxin injections

surgical fasciotomy

Arm Description

Botulinum toxin injections for chronic compartment syndrome

surgical fasciotomy for chronic compartment syndrome

Outcomes

Primary Outcome Measures

Lower Extremity Function index
Pain relief and increased function

Secondary Outcome Measures

Full Information

First Posted
November 8, 2017
Last Updated
June 29, 2020
Sponsor
375th Medical Group, Scott Air Force Base
search

1. Study Identification

Unique Protocol Identification Number
NCT03339921
Brief Title
Botulinum for Chronic Exertional Compartment Syndrome
Acronym
Botox
Official Title
Comparison of Botulinum Toxin to Fasciotomy in Treatment of Chronic Exertional Compartment Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
June 2020
Overall Recruitment Status
Terminated
Why Stopped
This study is being closed because it is unworkable.
Study Start Date
December 7, 2018 (Actual)
Primary Completion Date
May 1, 2020 (Actual)
Study Completion Date
May 1, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
375th Medical Group, Scott Air Force Base

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
We will investigate the feasibility of a simple outpatient one time injection regimen for the treatment of Chronic Exertional Compartment Syndrome (CECS). We think botulinum toxin injections will be a potentially cost-effective, low-risk alternative to surgery in reducing pain and returning patients to full activity.
Detailed Description
The study will be a prospective cohort pilot study designed to compare Active Duty patients, 18 years of age or older, with Chronic Exertional Compartment Syndrome (CECS) undergoing two different treatment interventions. The first arm will be patients receiving investigational botulinum toxin injections. The second arm will be patients who undergo the standard of care surgical fasciotomy. Both arms will be evaluated for pain relief with the universal pain scale and lower extremity functional index (LEFI) surveys at pre-treatment and again at one, three, and six months post-treatment. Clinical data that will be analyzed for research purposes in both groups include age, sex, height, weight, body mass index, time to diagnosis, minutes of exercise prior to onset of symptoms, minutes of rest before relief of symptoms, LEFI and pain on the Universal Pain Assessment Tool.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Exertional Compartment Syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
3 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Botulinum toxin injections
Arm Type
Experimental
Arm Description
Botulinum toxin injections for chronic compartment syndrome
Arm Title
surgical fasciotomy
Arm Type
Active Comparator
Arm Description
surgical fasciotomy for chronic compartment syndrome
Intervention Type
Drug
Intervention Name(s)
Botulinum toxin injections for chronic compartment syndrome
Intervention Description
Botulinum toxin will be injected in the upper and lower portion of the affected area with a syringe
Intervention Type
Procedure
Intervention Name(s)
surgical fasciotomy for chronic compartment syndrome
Intervention Description
linear incisions will be made into the affected compartment releasing the underlying fascial layer, reducing the pressure of the compartment
Primary Outcome Measure Information:
Title
Lower Extremity Function index
Description
Pain relief and increased function
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult ages 18-65 Active duty military Unable to run 1.5 miles without producing symptoms, including aching, burning, numbness, tingling, or weakness in the affected limb Failed conservative treatment over a period of 2 months, including trial of rest, NSAIDs, icing, and stretching routine Meets standard of care clinical diagnostic intramuscular compartment pressure criteria for CECS, based on standardized IMP needle testing. See below for testing protocol and criteria. Exclusion Criteria: Prior Botulinum toxin injections into the affected limb Prior compartment release of the affected limb Pregnant or becomes pregnant during the study Standard of care clinical exams indicating other more likely causes of leg pain
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brett Boyce, MD
Organizational Affiliation
Principal Investigator
Official's Role
Principal Investigator
Facility Information:
Facility Name
375th Medical Group
City
Scott Air Force Base
State/Province
Illinois
ZIP/Postal Code
62225
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Botulinum for Chronic Exertional Compartment Syndrome

We'll reach out to this number within 24 hrs